Long non-coding RNA EPIC1 inhibits viability and invasion of osteosarcoma cells by promoting MEF2D ubiquitylation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long non-coding RNA EPIC1 inhibits viability and invasion of osteosarcoma cells by promoting MEF2D ubiquitylation

Published:2019-05 Issue: Volume:128 Page:566-573
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Zhao Wei,Zhang Da,Qin Pan,Zhang Jiao,Cui Xichun,Gao Jing,Wang Jiaxiang,Li Juan

Funder

Medical Science and Technology Research Project of Henan Province

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference28 articles.

1. Osteosarcoma;Meyers;Pediatr. Clin. N. Am.,1997

2. The epidemiology of osteosarcoma;Ottaviani;Cancer Treat. Res.,2009

3. The therapy of osteogenic sarcoma: current status and thoughts for the future;Friedman;J. Surg. Oncol.,2010

4. Biology and therapeutic advances for pediatric osteosarcoma;Neyssa;Oncologist,2004

5. MEF2: a central regulator of diverse developmental programs;Potthoff;Development,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Ubiquitination in Osteosarcoma Development and Therapies;Biomolecules;2024-07-03

2. Identification of two MEF2s and their role in inhibiting the transcription of the mstn2a gene in the yellowfin seabream, Acanthopagrus latus (Hottuyn, 1782);Gene;2024-05

3. Combination of hsa_circ_0004674 and lncRNA OIP5‑AS1 as a novel clinical biomarker used to predict prognosis in patients with osteosarcoma;Experimental and Therapeutic Medicine;2023-03-23

4. Roles of lncRNAs in childhood cancer: Current landscape and future perspectives;Frontiers in Oncology;2023-02-27

5. LncRNAs could play a vital role in osteosarcoma treatment: Inhibiting osteosarcoma progression and improving chemotherapy resistance;Frontiers in Genetics;2023-01-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3